Article Text
Therapeutics/Prevention
Randomised controlled trial
Weekly adalimumab significantly reduces the number of abscesses and inflammatory nodules in patients with moderate to severe hidradenitis suppurativa
Statistics from Altmetric.com
Footnotes
Competing interests None declared.
Ethics approval Local Ethical Committees.
Provenance and peer review Commissioned; internally peer reviewed.